Abstract:Objective: This study aimed to evaluate the efficacy of α-thalassemia gene testing as a part of an antenatal intervention program over a 10-year period. Methods: All patients underwent α-thalassemia gene testing, which included the analysis of three types of deletions and mutations. Rare α-thalassemia gene testing was performed using Sanger sequencing, multiplex ligation-dependent probe amplification, and sequencing techniques. Prenatal diagnosis was performed in high-risk couples using chorionic villus sampling or amniocentesis. Results: From 2010 to 2019, among the 91,852 patients examined, α-thalassemia mutations were identified in 41.78% of patients. The most frequent α 0 gene mutation was-- SEA , followed by-- THAI . Two rare α 0 -thalassemia gene mutations at -- 32.8 and -- 230 , were also observed. A total of 2,235 high-risk couples were identified, of which 562 were affected, including three with the-- SEA /-- THAI genotype and one with the-- SEA /-- 230 genotype. Additionally, prenatal diagnosis revealed four cases of fetal anemia and/or mild edema, along with two cases of severe fetal edema. Chromosome and gene chip results were normal. Thalassemia gene testing showed an α CS α/α CS α genotype in four patients with anemia and/or mild edema, while two patients with severe fetal edema had one-- SEA /α CS α genotype and one-- SEA /-- GX genotype. Using the cut-off points of 74.6 fL and 24.4 pg as criteria for identifying α 0 -thalassemia carriers and HbH disease, the detection rate of missed diagnoses in high-risk couples is consistent with national guidelines for standards, potentially saving 10,217,700 ¥. Conclusion: Routine molecular testing for α-thalassemia in high-risk prenatal populations effectively prevented severe α-thalassemia births. Despite the high cost, the cutoff points proposed by this study suggest that implementing screening using a new parameter has the potential to reduce current expenses.

Detection of α-Thalassemia Gene Deletion with GAP-PCR

Preimplantation Genetic Diagnosis of Human Embryos with Α-Thalassemia

Detection of alpha-thalassemia in China by using multiplex ligation-dependent probe amplification

Accurate detection of α-globin gene copy number variants with two reactions using droplet digital PCR

Genetic screening of α-thalassemia fusion gene using routine flow-through hybridization

Gene mutation analysis in 481 suspected patients with thalassemia in certain area

Analysis of the drawback of the combination of MLPA and gene sequencing technology in detecting thalassemia genes

Development of a Quantitative Multiplex PCR to Detect Three Common Alpha Thalassemia Deletions

Detection of rare thalassemia mutations using long-read single-molecule real-time sequencing

Study on Prenatal Screening and Genotype Analysis of Α-Thalassemia

A Comprehensive Preimplantation Genetic Testing Approach for SEA-type Α-Thalassemia by Fluorescent Gap-Polymerase Chain Reaction Combined with Haplotype Analysis

Production of platelet-activating factor in inflammatory exudate.

Airway management in a baby with femoral hypoplasia–unusual facies syndrome

Development and clinical validation of a novel detection kit for α-thalassemia in southern Chinese

The Incidence of Thalassemia and the Analysis of Thalassemia-Associated Gene in Children in Guangzhou Region

[Rapid Detection of Non-Deletional Alpha-Thalassemia Mutations by PCR-LIS-SSCP].

Development And Validation Of A Zeta-Globin-Specific Elisa For Carrier Screening Of The (- -(Sea)) Alpha Thalassaemia Deletion

AB034. Hemoglobinopathies in China and SEA: Rapid Targeted Deep Sequencing for Molecular Screening and Clinical Genotyping in Subjects with Hemoglobinopathies

Routine antenatal molecular testing for α-thalassemia at a tertiary referral hospital in China: ten years of experience

Detection of the Point Mutations of α-Thalassemia by Reverse Dot Blot

A Nested Asymmetric PCR Melting Curve Assay for One-Step Genotyping of Nondeletional α-Thalassemia Mutations